Sweden’s Karolinska Ends All Use of Puberty Blockers and Cross-Sex Hormones for Minors Outside of Clinical Studies | SEGM
Our organization is an international nonprofit dedicated to promoting evidence-based principles and high-quality research within the field of youth gender medicine.